Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-06-27 Sale | 2019-07-02 9:09 pm | MELINTA THERAPEUTICS INC. | MLNT | JOHNSON JOHN Chief Executive Officer | 13,000 | $5.5724 | $72,441 | 37,400 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-15 Other | 2024-04-01 5:43 pm | N/A N/A | Xeris Biopharma Holdings Inc. | XERS | JOHNSON JOHN Director | 89,571 | $0 | 930,554 (Direct) | View |
| 2024-03-18 Exercise | 2024-03-18 5:32 pm | N/A 2029-11-14 | Xeris Biopharma Holdings Inc. | XERS | JOHNSON JOHN Director | 215,600 | $0 | 751,412 (Direct) | View |
| 2024-03-18 Exercise | 2024-03-18 5:32 pm | N/A N/A | Xeris Biopharma Holdings Inc. | XERS | JOHNSON JOHN Director | 215,600 | $1.99 | 751,412 (Direct) | View |
| 2024-03-11 Option Award | 2024-03-13 6:14 pm | N/A 2034-03-11 | Verastem Inc. | VSTM | JOHNSON JOHN Director | 8,549 | $0 | 8,549 (Direct) | View |
| 2024-03-11 Disposition | 2024-03-13 6:14 pm | N/A 2030-01-03 | Verastem Inc. | VSTM | JOHNSON JOHN Director | 8,549 | $0 | 8,549 (Direct) | View |
| 2023-09-01 Option Award | 2023-09-07 06:29 am | N/A 2033-09-01 | Axogen Inc. | AXGN | JOHNSON JOHN Director | 32,340 | $0 | 32,340 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-07 4:59 pm | N/A N/A | Xeris Biopharma Holdings Inc. | XERS | JOHNSON JOHN Director | 42,500 | $0 | 535,812 (Direct) | View |
| 2023-06-01 Exercise | 2023-06-05 6:53 pm | N/A N/A | Axogen Inc. | AXGN | JOHNSON JOHN Director | 6,459 | $0 | 6,459 (Direct) | View |
| 2023-05-15 Option Award | 2023-05-16 4:33 pm | N/A 2033-05-15 | Verastem Inc. | VSTM | JOHNSON JOHN Director | 62,500 | $0 | 62,500 (Direct) | View |
| 2022-05-12 Option Award(A) | 2022-12-20 4:07 pm | N/A 2032-05-12 | Verastem Inc. | VSTM | JOHNSON JOHN Director | 62,500 | $0 | 62,500 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 4:11 pm | N/A 2032-06-22 | Verastem Inc. | VSTM | JOHNSON JOHN Director | 62,500 | $0 | 62,500 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-09 5:13 pm | 2022-06-08 2032-06-08 | Xeris Biopharma Holdings Inc. | XERS | JOHNSON JOHN Director | 40,000 | $0 | 518,312 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-03 4:14 pm | N/A 2032-06-01 | Axogen Inc. | AXGN | JOHNSON JOHN Director | 18,270 | $0 | 18,270 (Direct) | View |
| 2021-10-05 Option Award(A) | 2021-10-08 6:29 pm | N/A 2025-10-16 | Xeris Biopharma Holdings Inc. | XERS | JOHNSON JOHN Director | 866,959 | $0 | 886,609 (Direct) | View |
| 2021-10-05 Option Award(A) | 2021-10-08 6:29 pm | N/A 2031-10-05 | Xeris Biopharma Holdings Inc. | XERS | JOHNSON JOHN Director | 19,650 | $2.37 | 886,609 (Direct) | View |
| 2021-10-05 Disposition | 2021-10-06 7:42 pm | N/A N/A | Strongbridge Biopharma plc | SBBP | JOHNSON JOHN Chief Executive Officer | 1,105,816 | $0 | 0 (Direct) | View |
| 2021-10-05 Option Award | 2021-10-05 7:52 pm | N/A 2025-10-16 | Xeris Biopharma Holdings Inc. | XERS | JOHNSON JOHN Director | 866,959 | $0 | 866,959 (Direct) | View |
| 2021-10-01 Tax Withholding | 2021-10-05 7:24 pm | N/A N/A | Strongbridge Biopharma plc | SBBP | JOHNSON JOHN Chief Executive Officer | 334,868 | $2.06 | 610,092 (Direct) | View |
| 2021-07-19 Option Award | 2021-07-21 4:10 pm | N/A 2031-07-19 | Axogen Inc. | AXGN | JOHNSON JOHN Director | 27,638 | $0 | 27,638 (Direct) | View |
| 2021-07-02 Tax Withholding | 2021-07-07 5:01 pm | N/A N/A | Strongbridge Biopharma plc | SBBP | JOHNSON JOHN Chief Executive Officer | 50,867 | $3.08 | 944,960 (Direct) | View |
| 2021-06-28 Option Award | 2021-06-30 2:00 pm | N/A 2031-06-28 | Verastem Inc. | VSTM | JOHNSON JOHN Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-04-08 Tax Withholding | 2021-04-09 5:13 pm | N/A N/A | Strongbridge Biopharma plc | SBBP | JOHNSON JOHN Chief Executive Officer | 17,325 | $2.68 | 995,827 (Direct) | View |
| 2021-01-07 Option Award | 2021-01-08 08:33 am | N/A N/A | Strongbridge Biopharma plc | SBBP | JOHNSON JOHN Chief Executive Officer | 491,000 | $0 | 1,013,152 (Direct) | View |
| 2020-07-02 Option Award | 2020-07-07 08:11 am | N/A N/A | Strongbridge Biopharma plc | SBBP | JOHNSON JOHN Chief Executive Officer | 315,000 | $0 | 522,152 (Direct) | View |
| 2020-07-02 Disposition | 2020-07-02 4:29 pm | N/A 2030-06-11 | PORTOLA PHARMACEUTICALS INC | PTLA | JOHNSON JOHN Director | 11,377 | $0.06 | 0 (Direct) | View |
| 2020-07-02 Disposition | 2020-07-02 4:29 pm | N/A N/A | PORTOLA PHARMACEUTICALS INC | PTLA | JOHNSON JOHN Director | 20,475 | $18 | 0 (Direct) | View |
| 2020-07-02 Disposition | 2020-07-02 4:29 pm | N/A N/A | PORTOLA PHARMACEUTICALS INC | PTLA | JOHNSON JOHN Director | 54,991 | $0 | 0 (Direct) | View |
| 2020-06-16 Option Award | 2020-06-18 5:31 pm | N/A 2030-06-16 | Verastem Inc. | VSTM | JOHNSON JOHN Director | 27,602 | $0 | 27,602 (Direct) | View |
| 2020-06-12 Option Award | 2020-06-15 6:59 pm | N/A 2030-06-11 | PORTOLA PHARMACEUTICALS INC | PTLA | JOHNSON JOHN Director | 18,658 | $0 | 31,852 (Direct) | View |
| 2020-05-15 Tax Withholding | 2020-05-18 4:51 pm | N/A N/A | Strongbridge Biopharma plc | SBBP | JOHNSON JOHN Executive Chairman | 15,348 | $2.86 | 207,152 (Direct) | View |
| 2020-04-29 Option Award | 2020-04-29 6:19 pm | N/A 2030-04-29 | Verastem Inc. | VSTM | JOHNSON JOHN Director | 25,000 | $0 | 25,000 (Direct) | View |
Ownership | 2020-04-29 6:14 pm | N/A 2030-01-03 | Verastem Inc. | VSTM | JOHNSON JOHN Director | 0 | $0 | 25,000 (Direct) | View |
| 2020-04-08 Option Award | 2020-04-10 08:07 am | N/A 2030-04-08 | Strongbridge Biopharma plc | SBBP | JOHNSON JOHN Executive Chairman | 270,000 | $0 | 310,000 (Direct) | View |
| 2019-11-14 Option Award | 2019-11-18 5:33 pm | N/A 2029-11-14 | Strongbridge Biopharma plc | SBBP | JOHNSON JOHN Executive Chairman | 275,000 | $0 | 275,000 (Direct) | View |
| 2019-05-22 Exercise | 2019-06-26 4:06 pm | N/A N/A | MELINTA THERAPEUTICS INC. | MLNT | JOHNSON JOHN Director | 50,000 | $0 | 400,400 (Direct) | View |
| 2019-06-13 Option Award | 2019-06-17 5:26 pm | N/A 2029-06-12 | PORTOLA PHARMACEUTICALS INC | PTLA | JOHNSON JOHN Director | 11,185 | $0 | 20,185 (Direct) | View |
| 2019-05-15 Option Award | 2019-05-16 4:12 pm | N/A N/A | Strongbridge Biopharma plc | SBBP | JOHNSON JOHN Director | 40,000 | $0 | 40,000 (Direct) | View |